|
1
|
Gomaa AI, Khan SA, Toledano MB, Waked I
and Taylor-Robinson SD: Hepatocellular carcinoma: Epidemiology,
risk factors and pathogenesis. World J Gastroenterol. 14:4300–4308.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Guo Z, Wu C, Wang X, Wang C, Zhang R and
Shan B: A polymorphism at the miR-502 binding site in the
3′-untranslated region of the histone methyltransferase SET8 is
associated with hepatocellular carcinoma outcome. Int J Cancer.
131:1318–1322. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Guo Z, Li LQ, Jiang JH, Ou C, Zeng LX and
Xiang BD: Cancer stem cell markers correlate with early recurrence
and survival in hepatocellular carcinoma. World J Gastroenterol.
20:2098–2106. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li X, Yang W, Lou L, Chen Y, Wu S and Ding
G: MicroRNA: A promising diagnostic biomarker and therapeutic
target for hepatocellular carcinoma. Dig Dis Sci. 59:1099–1107.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Minagawa M, Makuuchi M, Takayama T and
Kokudo N: Selection criteria for repeat hepatectomy in patients
with recurrent hepatocellular carcinoma. Ann Surg. 238:703–710.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Callegari E, Gramantieri L, Domenicali M,
D'Abundo L, Sabbioni S and Negrini M: MicroRNAs in liver cancer: A
model for investigating pathogenesis and novel therapeutic
approaches. Cell Death Differ. 22:46–57. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lee RC, Feinbaum RL and Ambros V: The
C. elegans heterochronic gene lin-4 encodes small RNAs with
antisense complementarity to lin-14. Cell. 75:843–854. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bagga S, Bracht J, Hunter S, Massirer K,
Holtz J, Eachus R and Pasquinelli AE: Regulation by let-7 and lin-4
miRNAs results in target mRNA degradation. Cell. 122:553–563. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kuehbacher A, Urbich C, Zeiher AM and
Dimmeler S: Role of Dicer and Drosha for endothelial microRNA
expression and angiogenesis. Circ Res. 101:59–68. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Barbato C, Ciotti MT, Serafino A,
Calissano P and Cogoni C: Dicer expression and localization in
post-mitotic neurons. Brain Res. 1175:17–27. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cochrane DR, Cittelly DM, Howe EN,
Spoelstra NS, McKinsey EL, LaPara K, Elias A, Yee D and Richer JK:
MicroRNAs link estrogen receptor alpha status and Dicer levels in
breast cancer. Horm Cancer. 1:306–319. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dedes KJ, Natrajan R, Lambros MB, Geyer
FC, Lopez-Garcia MA, Savage K, Jones RL and Reis-Filho JS:
Down-regulation of the miRNA master regulators Drosha and Dicer is
associated with specific subgroups of breast cancer. Eur J Cancer.
47:138–150. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yan M, Huang HY, Wang T, Wan Y, Cui SD,
Liu ZZ and Fan QX: Dysregulated expression of Dicer and drosha in
breast cancer. Pathol Oncol Res. 18:343–348. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Caffrey E, Ingoldsby H, Wall D, Webber M,
Dinneen K, Murillo LS, Inderhaug C, Newell J, Gupta S and Callagy
G: Prognostic significance of deregulated Dicer expression in
breast cancer. PLoS One. 8:e837242013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Karube Y, Tanaka H, Osada H, Tomida S,
Tatematsu Y, Yanagisawa K, Yatabe Y, Takamizawa J, Miyoshi S,
Mitsudomi T and Takahashi T: Reduced expression of Dicer associated
with poor prognosis in lung cancer patients. Cancer Sci.
96:111–115. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Merritt WM, Lin YG, Han LY, Kamat AA,
Spannuth WA, Schmandt R, Urbauer D, Pennacchio LA, Cheng JF, Nick
AM, et al: Dicer, Drosha, and outcomes in patients with ovarian
cancer. N Engl J Med. 359:2641–2650. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Köbel M, Gilks CB and Huntsman DG: Dicer
and Drosha in ovarian cancer. N Engl J Med. 360:1150–1151; author
reply 1151. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pampalakis G, Diamandis EP, Katsaros D and
Sotiropoulou G: Down-regulation of Dicer expression in ovarian
cancer tissues. Clin Biochem. 43:324–327. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lin RJ, Lin YC, Chen J, Kuo HH, Chen YY,
Diccianni MB, London WB, Chang CH and Yu AL: MicroRNA signature and
expression of Dicer and Drosha can predict prognosis and delineate
risk groups in neuroblastoma. Cancer Res. 70:7841–7850. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zeng S, Yang J, Zhao J, Liu Q, Rong M, Guo
Z and Gao W: Silencing Dicer expression enhances cellular
proliferative and invasive capacities in human tongue squamous cell
carcinoma. Oncol Rep. 31:867–873. 2014.PubMed/NCBI
|
|
22
|
Zhu DX, Fan L, Lu RN, Fang C, Shen WY, Zou
ZJ, Wang YH, Zhu HY, Miao KR, Liu P, et al: Downregulated Dicer
expression predicts poor prognosis in chronic lymphocytic leukemia.
Cancer Sci. 103:875–881. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Guo X, Liao Q, Chen P, Li X, Xiong W, Ma
J, Li X, Luo Z, Tang H, Deng M, et al: The microRNA-processing
enzymes: Drosha and Dicer can predict prognosis of nasopharyngeal
carcinoma. J Cancer Res Clin Oncol. 138:49–56. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu JF, Shen W, Liu NZ, Zeng GL, Yang M,
Zuo GQ, Gan XN, Ren H and Tang KF: Down-regulation of Dicer in
hepatocellular carcinoma. Med Oncol. 28:804–809. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kitagawa N, Ojima H, Shirakihara T,
Shimizu H, Kokubu A, Urushidate T, Totoki Y, Kosuge T, Miyagawa S
and Shibata T: Downregulation of the microRNA biogenesis components
and its association with poor prognosis in hepatocellular
carcinoma. Cancer Sci. 104:543–551. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Edge SB, Byrd DR and Compton CC: The
American Joint Committee on Cancer: The 7th edition of the AJCC
cancer staging manual and the future of TNM. Ann Surg Oncol.
17:1471–1474. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Singh M, Zaino RJ, Filiaci VJ and Leslie
KK: Relationship of estrogen and progesterone receptors to clinical
outcome in metastatic endometrial carcinoma: A Gynecologic oncology
group study. Gynecol Oncol. 106:325–333. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang M and Zhou H: Grass carp transforming
growth factor-beta 1 (TGF-beta 1): Molecular cloning, tissue
distribution and immunobiological activity in teleost peripheral
blood lymphocytes. Mol Immunol. 45:1792–1798. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pugh RN, Murray-Lyon IM, Dawson JL,
Pietroni MC and Williams R: Transection of the oesophagus for
bleeding oesophageal varices. Br J Surg. 60:646–649. 1973.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jafarnejad SM, Ardekani GS, Ghaffari M,
Martinka M and Li G: Sox4-mediated Dicer expression is critical for
suppression of melanoma cell invasion. Oncogene. 32:2131–2139.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kuang Y, Cai J, Li D, Han Q, Cao J and
Wang Z: Repression of Dicer is associated with invasive phenotype
and chemoresistance in ovarian cancer. Oncol Lett. 5:1149–1154.
2013.PubMed/NCBI
|
|
33
|
Bian XJ, Zhang GM, Gu CY, Cai Y, Wang CF,
Shen YJ, Zhu Y, Zhang HL, Dai B and Ye DW: Down-regulation of Dicer
and Ago2 is associated with cell proliferation and apoptosis in
prostate cancer. Tumour Biol. 35:11571–11578. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Faber C, Horst D, Hlubek F and Kirchner T:
Overexpression of Dicer predicts poor survival in colorectal
cancer. Eur J Cancer. 47:1414–1419. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Faggad A, Budczies J, Tchernitsa O,
Darb-Esfahani S, Sehouli J, Müller BM, Wirtz R, Chekerov R,
Weichert W, Sinn B, et al: Prognostic significance of Dicer
expression in ovarian cancer-link to global microRNA changes and
oestrogen receptor expression. J Pathol. 220:382–391.
2010.PubMed/NCBI
|
|
36
|
Gao C, Li X, Tong B, Wu K, Liu Y, Anniko M
and Duan M: Up-regulated expression of Dicer reveals poor prognosis
in laryngeal squamous cell carcinoma. Acta Otolaryngol.
134:959–963. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Nakagawa A, Shi Y, Kage-Nakadai E, Mitani
S and Xue D: Caspase-dependent conversion of Dicer ribonuclease
into a death-promoting deoxyribonuclease. Science. 328:327–334.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Krill KT, Gurdziel K, Heaton JH, Simon DP
and Hammer GD: Dicer deficiency reveals microRNAs predicted to
control gene expression in the developing adrenal cortex. Mol
Endocrinol. 27:754–768. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wu YY, Chen L, Wang GL, Zhang YX, Zhou JM,
He S, Qin J and Zhu YY: Inhibition of hepatocellular carcinoma
growth and angiogenesis by dual silencing of NET-1 and VEGF. J Mol
Histol. 44:433–445. 2013. View Article : Google Scholar : PubMed/NCBI
|
